Biochemical and functional characterization of mutant KRAS epitopes validates this oncoprotein for immunological targeting

Activating RAS missense mutations are among the most prevalent genomic alterations observed in human cancers and drive oncogenesis in the three most lethal tumor types. Emerging evidence suggests mutant KRAS (mKRAS) may be targeted immunologically, but mKRAS epitopes remain poorly defined. Here we e...

Descripción completa

Detalles Bibliográficos
Autores principales: Bear, Adham S., Blanchard, Tatiana, Cesare, Joseph, Ford, Michael J., Richman, Lee P., Xu, Chong, Baroja, Miren L., McCuaig, Sarah, Costeas, Christina, Gabunia, Khatuna, Scholler, John, Posey, Avery D., O’Hara, Mark H., Smole, Anze, Powell, Daniel J., Garcia, Benjamin A., Vonderheide, Robert H., Linette, Gerald P., Carreno, Beatriz M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285372/
https://www.ncbi.nlm.nih.gov/pubmed/34272369
http://dx.doi.org/10.1038/s41467-021-24562-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285372/
https://www.ncbi.nlm.nih.gov/pubmed/34272369
http://dx.doi.org/10.1038/s41467-021-24562-2

Ejemplares similares